ARTELO BIOSCIENCES, INC. Increase (Decrease) in Other Receivables
ARTELO BIOSCIENCES, INC. (ARTL) reported Increase (Decrease) in Other Receivables of -$13.34 thousand for the 12-month period ending 2019-08-31, per its 10-K filed 2020-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2020-11-04
- ARTELO BIOSCIENCES, INC. increase (decrease) in other receivables for the quarter ending 2019-02-28 was $5.49K, a 880.18% increase year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in other receivables for the quarter ending 2018-11-30 was -$18.66K, a 2533.51% decline year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in other receivables for the quarter ending 2018-08-31 was $5.64K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in other receivables for the quarter ending 2018-05-31 was $15.16K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in other receivables for fiscal 2019 was -$13.34K, a 160.29% decline from fiscal 2018.
- ARTELO BIOSCIENCES, INC. increase (decrease) in other receivables for fiscal 2018 was $22.13K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in other receivables for fiscal 2017 was $0.00.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2019-08-31 | -$13.34K 10-K · filed 2020-11-04 | |||
| 2019-02-28 | $5.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | -$13.18K 10-Q · filed 2019-04-15 | -$7.53K derived: sum of 3 quarters · filed 2019-12-18 | $7.62K derived: sum of 4 quarters · filed 2019-12-18 |
| 2018-11-30 | -$18.66K 10-Q · filed 2019-01-14 | -$13.02K derived: sum of 2 quarters · filed 2019-12-18 | $2.13K derived: sum of 3 quarters · filed 2019-12-18 | $2.69K derived: sum of 4 quarters · filed 2019-12-18 |
| 2018-08-31 | $5.64K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | $20.80K derived: sum of 2 quarters · filed 2019-12-18 | $21.36K derived: sum of 3 quarters · filed 2019-12-18 | $22.13K 10-K/A · filed 2019-12-18 |
| 2018-05-31 | $15.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $15.72K derived: sum of 2 quarters · filed 2019-04-15 | $16.48K 10-Q · filed 2018-07-13 | |
| 2018-02-28 | $560.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $1.33K 10-Q · filed 2019-04-15 | ||
| 2017-11-30 | $767.00 10-Q · filed 2019-01-14 | |||
| 2017-08-31 | $0.00 10-K · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |